Regenerative Medicine for Foot & Ankle Conditions

Advanced PRP & Cellular Therapies Offered In-Office and in the Operating Room

 

What is Regenerative Medicine?

Regenerative medicine uses the body’s own cells (Platelets, Mesenchymal Stem Cells, and Leukocytes) to promote healing, modulate inflammation, and accelerate recovery. Whether you’re healing from a sports injury, struggling with chronic wounds, or undergoing cosmetic surgery, our therapies are designed to optimize your recovery timeline.

 

   

           Draw                                      Spin                                         Place

 

 

Office-Based Treatment

Ultrasound-Guided PRP Injections

 

 

How It Works: Blood is drawn directly from the patient and concentrated via centrifugation to obtain platelet-rich plasma (PRP). Containing concentrated tissue growth factors and immune modulating cytokines, PRP is injected around injured soft tissue structures under ultrasound guidance to recreate an acute wound healing environment.

 

Indications:

• Achilles tendinopathy
• Plantar fasciitis
• Peroneal and posterior tibial tendonitis
• Ankle ligament injuries (e.g., ATF Sprain)

 

Benefits:

• Performed in-office under ultrasound guidance
• Minimal downtime
• Non-steroidal, minimally invasive treatment option
• $500.00 per application

 

 

Regenerative Wound Care

 

PRP for Chronic Ulcer Healing

How It Works: Blood is drawn directly from the patient and concentrated via centrifugation to obtain platelet-rich plasma (PRP). The antibacterial peptides and proliferative growth factors of the PRP are then applied directly to the wound – increasing tissue healing and reducing bacterial load.

 

Indications:

• Diabetic foot ulcers
• Venous stasis ulcers
• Burns
• Post-surgical wounds with delayed healing

 

Benefits:

• Can be applied weekly in the office setting
• Used alongside advanced wound dressings and skin substitutes (grafts)
• $150.00 per application (average of 5 applications to closure)

 

•  

Surgical Applications

 

Concentrated Bone Marrow Aspirate (BMC) During Surgery

 

 

How It Works: Bone Marrow Aspirate (BMA), often taken from the heel or tibia, is rich in Mesenchymal Stem Cells (MSC). These cells are combined with the enabling growth factors of PRP and centrifuged to form an MSC-Rich Matrix that can be applied directly to surgical sites for supportive healing.

 

Indications:

• Cosmetic foot and ankle surgery*
• Reconstructive foot surgery
• Limb salvage procedures
• Ligament and tendon injuries
• Lower extremity trauma and fracture care

 

Benefits:

• Attenuated post-operative pain, inflammation, and scarring
• Minimally invasive, non-surgical treatment modality
• Increased cellular proliferation potential at surgical state
• $3,500 for preparation and injection

 

 

Why Choose Our Practice?

• Leaders in regenerative medical treatment of the foot and ankle
• On-site ultrasound and PRP processing
• Proven outcomes in both sports injuries, cosmetic foot surgery, and wound healing

 

 

NOTE TO PATIENTS

Platelet-rich plasma (PRP) and Mesenchymal Stem Cell (MSC) therapy is an investigational and evolving field within regenerative medicine. While many patients report positive outcomes, individual results may vary and cannot be guaranteed. Factors such as age, overall health, the severity of the condition being treated, and adherence to post-procedure recommendations can influence outcomes. PRP therapy is not FDA-approved for all conditions, and its use is considered off-label in many applications.

By proceeding with treatment, patients acknowledge that PRP or MSC therapy may not result in symptom relief, functional improvement, or tissue regeneration, and that additional treatments or alternative therapies may be necessary. This therapy does not replace standard medical care or surgical intervention when indicated.

*No express or implied warranties or guarantees of outcome are provided*

 

NOTE TO REGULATORS

All our procedures are autologous and performed on the same day. Any off-label use of medications or products is fully disclosed to the patient. We strive to be compliant with the latest relevant FDA regulatory guidelines pertaining to:

• Investigational New Drug & Biological License Applications (IND/BLA)
• Regenerative Medicine Advanced Therapy (RMAT)
• Section 351 & 361 Human Cellular and Tissue Product (HCT/P) guidelines